Story perspectives

Oura Files $11B IPO, Targets $1.5B 2026 Revenue

5/22/2026

Summary

Oura Health IPO

Oura Health Oy filed confidential IPO paperwork with the U.S. SEC, aiming to list this year.
The filing follows an $11 billion valuation after a $875 million funding round in September.
CEO Tom Hale said Oura sold 5.5 million rings and expects $1.5 billion revenue in 2026.
Goldman Sachs, Morgan Stanley, JPMorgan Chase, Allen & Co. and Jefferies are underwriting the IPO, making it the largest consumer-wearables listing since Peloton’s 2019 debut.

Summary

Oura Launches AI

Oura launched its Large Language Model in February 2026 to power the Oura Advisor chatbot for women’s health.
The webAI-built model runs on Oura’s servers, so conversations are never shared or sold.
Chief Medical Officer Dr. Ricky Bloomfield said the AI merges biometric signals with vetted knowledge to address women’s health complexities.
Oura offers the AI through Oura Labs app section after moving its headquarters from Finland to San Francisco in early 2026.

Summary

Oura Secures Ban

Oura secured a 2024 U.S. International Trade Commission import ban on Ultrahuman and signed a licensing deal with RingConn.
The ITC is probing Samsung, Zepp Health, Reebok and Noise for infringing Oura’s patents on curved battery placement and internal ring architecture.
Analysts call Oura’s patent portfolio a defensive moat, while rivals say claims are overly broad.
Samsung’s unresolved challenge to the patents could affect investor sentiment toward Oura’s upcoming IPO.

Summary

Oura Hits 5M

Oura projects more than 5 million paid members this quarter, a four-fold increase over two years.
Eighty percent of users renew after the first year, drawn by personalized sleep, stress, metabolism and women’s health data.
Over half of members have a chronic condition and 80 % use ring data to guide treatment.
Oura is in 4.6 k retail sites and partners with 1.2 k enterprises to test blood-pressure and AI-decoded blood-work features.

History

Historical Context

Founded on March 26 2007, Fitbit went public in June 2015, raising $732 million in what co-founder James Park called the largest consumer-electronics IPO in U.S. history. The company’s success paved the way for Oura Health’s this confidential 2024 IPO filing, led by Goldman Sachs, Morgan Stanley and JPMorgan Chase, which targets a global valuation above $11 billion.

1 of 5

Oura Health IPO

Oura Health Oy filed confidential IPO paperwork with the U.S. SEC, aiming to list this year.
The filing follows an $11 billion valuation after a $875 million funding round in September.
CEO Tom Hale said Oura sold 5.5 million rings and expects $1.5 billion revenue in 2026.
Goldman Sachs, Morgan Stanley, JPMorgan Chase, Allen & Co. and Jefferies are underwriting the IPO, making it the largest consumer-wearables listing since Peloton’s 2019 debut.

1 / 5